Susquehanna International Group’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Susquehanna International Group’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-41,000	Closed	-$40.2K	–	13486
2024 Q3	$40.2K	Sell	41,000 -62,700	-60%	-$67.2K	﹤0.01%	11456
2024 Q2	$127K	Sell	103,700 -7,100	-6%	-$12.1K	﹤0.01%	10856
2024 Q1	$420K	Buy	+110,800	New	+$208K	﹤0.01%	8927

Other funds holding OCEA

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

VPIM

Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.63B AUM 18.97% 1-Year Est. Return

Susquehanna International Group's OCEA Position: Q2 2025 in Review

Susquehanna International Group sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 98,427 shares — an estimated $5.32K sold.

Susquehanna International Group first reported a position in OCEA in Q1 2025 and held it in 1 quarter. The position peaked at $5.32K in Q1 2025. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

Susquehanna International Group reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Susquehanna International Group sold 98,427 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $5.32K.
Susquehanna International Group first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2025 and held it in 1 quarter.
Susquehanna International Group's Ocean Biomedical, Inc. Common Stock position peaked at $5.32K in Q1 2025.
7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.